EDP Biotech Corporation News
Follow our progress, be the first to know when ColoPlex™ with marker is available.
Dr. Anna podcast on Colorectal Cancer featuring EDP Biotech
Doctor Anna talks colorectal cancer with Eric Mayer and Jason Liggett, Ph.D from EDP biotech, a company that is focused on early detection methods for this devastating disease. Listen on YouTube!
Teknovation highlights EDP Biotech and upcoming SEBIO Investor Forum
by Tom Ballard - PYA Chief Alliance Officer Knoxville’s EDP Biotech Corporation is one of 17 companies – and the only one from Tennessee – invited to pitch during the Southeast BIO (SEBIO) Investor & Partnering Forum scheduled next week in Coral Gables, FL. “EDP...
EDP Biotech Selected for SEBIO 2019
Early Stage Companies Announced October 23, 2019 | 2019 News Entrepreneurs representing the most promising early stage bioscience and medical technology companies in the region will solicit advice and seek investment during the annual life science convention sponsored...
EDP Biotech selected for LSTCon Venture Forum
EDP Biotech has been selected as a finalist for LifeScience Tennessee LSTCon Venture Forum! The Venture Forum, sponsored by Waller Lansden Dortch & Davis, gives a platform to emerging life science startups to access funding and potential investment opportunities,...
EDP Biotech partners with 2nd Generation Capital (Nashville investment banking) to complete $5M Series A Round
10/20/2019 – EDP Biotech Corporation has recently partnered with 2nd Generation Capital for their advisory and investment banking services (d/b/a of BrightChoice Financial, LLC, FINRA CRD#147509), member FINRA & SIPC. 2ndG has been the lead adviser for debt &...
US Capital Global summarizes EDP Biotech $5M Advisory
San Francisco, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- US Capital Global has advised on a $5 million preferred equity facility for privately held medical device company, EDP Biotech Corporation (“EDP Biotech”), headquartered in Knoxville, TN. EDP Biotech is in...
Innov865 Week, Register Now!
Join EDP Biotech and Six of Knoxville’s most investable startups as they pitch their businesses on-stage at The Mill & Mine on September 24 before a panel of expert judges for a chance to win up to $10,000 in cash prizes, including a “crowd favorite” cash prize...
EDP Biotech selected by Innov865 Alliance as one of Knoxville’s most investable companies
Discover the trailblazers and innovators behind Knoxville’s growing startup community during 2019 Innov865 Week, coming up September 23 – 27, 2019. The annual entrepreneurship festival, hosted by the Innov865 Alliance, spotlights Knoxville as a great place to start...
Hundreds attend inaugural event for the new Knoxville Technology Council
ON AUGUST 18 TH, 2019 BY TOM BALLARD By Tom Ballard, Chief Alliance Officer, PYA When we interviewed Brandon Bruce for this recent article about the inaugural event for the new Knoxville Technology Council (KTech), he promised that it would be unique in a number of...
Knoxville’s EDP Biotech eyes $5MM Series A, atop $17.5MM raised
By Milt Capps Published June 18, 2019 Comment Print Chairman Tom Boyd, CEO Eric Mayer KNOXVILLE's EDP Biotech, which was chartered to commercialize assays for early detection of disease and is now focused on its blood-based ColoPlex™ test for colorectal...
Luminex, EDP Biotech Ink Deal for Colorectal Cancer Early Detection Blood Test
NEW YORK (GenomeWeb) – In vitro diagnostics developer EDP Biotech said today it has signed a deal with Luminex to develop, market, and sell a blood-based colorectal test using the xMAP technology. Terms of the deal were not disclosed. Called ColoPlex, the inexpensive...
EDP Biotech to Develop and Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP® Technology
KNOXVILLE, Tenn., May 28, 2019 /PRNewswire/ -- EDP Biotech Corporation, an in vitro diagnostics developer focused on early detection of disease, today announced that it has entered into a non-exclusive agreement with Luminex Corporation. According to the terms, EDP...